Febuxostat, a nonpurine selective inhibitor of xanthine oxidase: a promising medical therapy for chronic heart failure?
Gao
Ling-gen
LG
Department of Cardiology, Fu Wai Hospital and Cardiovascular Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.
Yao
Xiu-ping
XP
Zhang
Lin
L
Wen
Dan
D
Luo
Fang
F
Zhou
Xian-liang
XL
Hui
Ru-tai
RT
D000818:Animals; D002908:Chronic Disease; D000069465:Febuxostat; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D017382:Reactive Oxygen Species; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use*; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors*
D017382:Reactive Oxygen Species; D013844:Thiazoles; D000069465:Febuxostat; D014969:Xanthine Oxidase